Under a proposal in the Louisiana Legislature, pharmaceutical companies would have to disclose to a new Prescription Drug ...
Xaira Therapeutics today announced the appointment of Dr. Rachel Lane as Senior Vice President, Business Development and ...
You might be surprised to hear this, but off-the-shelf CAR-T therapies for cancer are still a thing. We preview an interesting data readout coming soon from Allogene Therapeutics.
DifGen Pharmaceuticals and Aveva Drug Delivery Systems today announced a strategic platform collaboration with Biostax Corp d/b/a Attune Biotech, SGP Holdings, and Callan JMB to lead U.S.-based ...
Insilico Medicine ('Insilico', 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, and Tenacia Biotechnology (Hong Kong) Co., Limited ('Tenacia'), a ...
Collaboration leverages MSK’s expertise to accelerate development of therapeutic candidates produced by ARIScience’s ...
Innate Pharma has finally called time on a NK cell engager in phase 1/2 development as part of an ongoing fine-tuning of the French biotech’s pipeline. | Innate Pharma has finally called time on a NK ...
14hon MSN
Over the past decade, early-stage drug innovation has shifted toward China, researchers find
Early-stage drug development worldwide has nearly doubled over the past decade and shifted from a U.S.-dominated model to a ...
Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed ...
Terrestrial Bio, which rebranded from Vaxess Technologies, is relocating its headquarters to Boston with $50 million in new funding for GLP-1 drug development.
While participants on a lower dose of Wave Life Sciences’ RNA therapy lost 5.3% total fat at the six-month mark, those ...
FDA grants Orphan Drug Designation to SignaBlok's first-in-class, new mechanism-based TREM-1 peptide inhibitor to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results